Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

30.800
-1.200-3.75%
Volume:- -
Turnover:- -
Market Cap:67.79B
PE:-15.98
High:30.800
Open:30.800
Low:30.800
Close:32.000
52wk High:37.360
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.928
ROE:-15.33%
ROA:1.54%
PB:2.22
PE(LYR):-15.98
PS:10.23

Loading ...

GenScript announces availability of 2025 ESG report

Reuters
·
Apr 14

Genscript: Legend Biotech Posts US$597.00 Million CARVYKTI® Net Sales for Q1 2026

Bulletin Express
·
Apr 14

A Look At GenScript Biotech (SEHK:1548) Valuation After New DNA Data Storage Collaboration With Mimulus

Simply Wall St.
·
Apr 13

GenScript Reports 2025 ESG Progress: 10% Emissions Drop, 58% Female Workforce and SBTi-Aligned Net-Zero Roadmap

Bulletin Express
·
Apr 13

GENSCRIPT BIO Sets 5 June 2026 AGM; Shareholders to Vote on FY-2025 Statements, Director Re-elections and 20% Issuance Mandate

Bulletin Express
·
Apr 13

GenScript Bio to Seek 20% Issuance Headroom, 10% Buy-Back Capacity and Charter Revamp at 5 June 2026 AGM

Bulletin Express
·
Apr 13

GenScript publishes 2025 environmental, social and governance report

Reuters
·
Apr 13

GenScript Biotech announces annual general meeting notice

Reuters
·
Apr 13

金斯瑞生物科技2025年营收大增61.4%至9.60亿美元,受Legend投资减值影响净亏损5.32亿美元

Bulletin Express
·
Apr 13

GenScript Biotech publishes 2025 annual report

Reuters
·
Apr 13

Genscript Bio Plans Fifth Amended Memorandum and Articles to Comply with Updated HKEX Rules

Bulletin Express
·
Apr 10

GenScript seeks shareholder approval for bylaw updates on hybrid meetings, e-voting, treasury shares

Reuters
·
Apr 10

GenScript partners with Mimulus to scale DNA-based data storage by 2030

Reuters
·
Apr 09

HK Movers | Pharmaceutical Stocks Rally With Joinn up 7%

Tiger Newspress
·
Apr 09

Genscript Bio Adds 1.53 Million New Shares in March 2026, Issued Capital Reaches 2.19 Billion

Bulletin Express
·
Apr 02

Jefferies Adjusts Yeahka's Price Target to HK$15.50 From HK$23, Keeps at Buy

MT Newswires Live
·
Apr 02

GENSCRIPT BIO (01548) 2025 Annual Report Review: Synergistic Growth Across Three Core Businesses Highlights Systemic Competitive Advantages and Long-Term Value

Stock News
·
Mar 18

Daiwa Cuts Target Price for GENSCRIPT BIO (01548) to HK$21, Reiterates "Buy" Rating

Stock News
·
Mar 18

Revised title

Deep News
·
Mar 18

Genscript Biotech Losses Narrow Sharply In First Half Reinforcing Profitability Narrative

Simply Wall St.
·
Mar 18